CINXE.COM

Novel Combination Cancer Immunotherapy Summit 2024

Novel Combination Cancer Immunotherapy Summit 2024

About

The Novel Combination Cancer Immunotherapy Summit 2024 covers topics such as: From the Lessons Learnt to Strategic Partnerships: Establishing the Roadmap Towards Novel and Synergistic Cancer Immunotherapy Combinations, Improving Response Rate and Durability of Your Drugs Through Rational and Synergistic Combination Strategies, Overcoming Complex Cancer Biology with Novel Multimodal Combinations Beyond Traditional Checkpoint Inhibitors, Reducing Toxicity Whilst Improving Potency Through Effective Patient Selection, Protocol Design and Dosage Optimization, Enhancing Patient Response Rate to Combination Therapies by Targeting the Tumor Microenvironment, Navigating Patient Selection, Dosing and Regulatory Considerations to Ensure Clinical Success for Novel Combination Cancer Immunotherapies, Achieving Better Translatability from Preclinical to Clinical Development with Smart Models, Resistance Investigation and Addressing Toxicity

Profile Details
Full Name
Novel Combination Cancer Immunotherapy Summit 2024
Start Date
2024-10-15
End Date
2024-10-17
Place Name
Sheraton Mission Valley San Diego Hotel
Street
1433 Camino Del Rio South
City
San Diego
Region
CA
Country
US
Address
Sheraton Mission Valley San Diego Hotel , 1433 Camino Del Rio South, San Diego, California, United States
Organization
Hanson Wade
Performers
Speakers or Exhibitors
Industry

The Novel Combination Cancer Immunotherapy Summit 2024 covers topics such as:

  • From the Lessons Learnt to Strategic Partnerships: Establishing the Roadmap Towards Novel & Synergistic Cancer Immunotherapy Combinations
  • Improving Response Rate & Durability of Your Drugs Through Rational & Synergistic Combination Strategies
  • Overcoming Complex Cancer Biology with Novel Multimodal Combinations Beyond Traditional Checkpoint Inhibitors
  • Reducing Toxicity Whilst Improving Potency Through Effective Patient Selection, Protocol Design & Dosage Optimization
  • Enhancing Patient Response Rate to Combination Therapies by Targeting the Tumor Microenvironment
  • Navigating Patient Selection, Dosing & Regulatory Considerations to Ensure Clinical Success for Novel Combination Cancer Immunotherapies
  • Achieving Better Translatability from Preclinical to Clinical Development with Smart Models, Resistance Investigation & Addressing Toxicity
Health & Medicine Conferences
Oncology Conferences
Pharma Conferences
Medical Ethics and Bioethics Conferences
Psychosomatic Medicine Conferences
Human Disease Conferences
Medical Informatics Conferences
Morbidity Conferences
Clinical Medicine Conferences
Disease Conferences
Doctors Conferences
Medicine Conferences
Medical Conferences
Physicians Conferences
Pharmaceutical Engineering Conferences
Pharmacy Pharmacology Conferences
Polypharmacy Conferences
Reproductive Pharmacology Conferences
Applied Pharmacology Conferences
Cancer Nursing Conferences
Cellular Immunology Conferences
Clinical Pharmacology Conferences
Drug Discovery Conferences
Nursing Pharmacology Conferences
Oncology Nursing Conferences
Orphan Drugs Conferences
Pharmaceuticals Conferences
Cancer Treatment Conferences
Clinical Pharmacy Conferences
Molecular Pharmacology Conferences
Pharmacodynamics Conferences
Antivirals Conferences
Brain Tumors Conferences
Drug Delivery Conferences
Drug Screening Conferences
Ethnopharmacology Conferences
Ocular Pharmacology Conferences
Pharmaceutical Chemistry Conferences
Pharmacognosy Conferences
Psychopharmacology Conferences
Bioavailability Conferences
Bioequivalence Conferences
Malignant Conferences
Tumor Conferences
Drug Conferences
Medications Conferences
Enzymes Conferences
Medicinal Conferences
Medical Writing Conferences
Lipid Nanoparticles (LNP) Conferences
Cancer Conferences
Cell Therapy Conferences
Cellular Therapy Conferences
Cell Transplantation Conferences
Cytotherapy Conferences
Immunotherapy Conferences
Immunotherapies Conferences
Lymphoma Conferences
Malignancy Conferences
Malignancies Conferences
Tumor Treatment Conferences
Medication Conferences
Pharmaceutical Conferences
Drugs Conferences
Generics Conferences
Vaccines Conferences
Inhibitors Conferences
Receptors Conferences
Pharmacy Conferences
Pharmacies Conferences
Pharmacokinetics Conferences
Biopharmaceuticals Conferences
Prescriptions Conferences
Clinical Trials Conferences
Neuropharmacology Conferences
Pharmacovigilance Conferences
Pharmacology Conferences
Pharmacologists Conferences
Pharmacological Conferences
Epharma Conferences
Biopharma Conferences
Therapy Conferences
Therapies Conferences
Antibiotics Conferences
Biochemical Pharmacology Conferences
Breast Cancer Conferences
Chemotherapy Conferences
Clinical Applications Conferences
Drug Development Conferences
Drug Toxicity Conferences
Novel Combination Cancer Immunotherapy Summit 2024 - 15-17 Oct 2024, Sheraton Mission Valley San Diego Hotel, California, United States
5th International Conference on Immunology and Immunotherapy - 24-25 Oct 2024 - Zurich, Switzerland
9th International Conference on Cancer Research & Drug Development (CRD 2024) - 18-20 Nov 2024 - Newton, United States
15th World Bispecific Summit 2024 - 03-05 Sep 2024 - Cambridge, United States
Sustainable Brands (SB 2024) - San Diego
Antibiotics
Validation of Palliative Prognostic Index for Terminal Cancer Patients in Hospice Consultation Setting in Taiwan
A Population based Colorectal Cancer Screening Program
Efficiency Of Proteolytic Enzymes In Treating Lumbar Spine Osteoarthritis (Low Back Pain) Patients And Its Effects On Liver And Kidney Enzymes
GI and Oncologic Surgery - Unusal Presentations of Meckel`s Diverticulum
The Importance of Oncology Conferences